Efficacy of Point Of Service Testing in MBC

Efficacy of Point Of Service Testing in Metastatic Breast Cancer

This study will assess the efficacy of an innovative point of service cancer genetics counseling delivery model for metastatic breast cancer (MBC) patients whom have received a referral for hereditary cancer genetic counseling and testing.

Inclusion Criteria:

• Ability of participant OR Legally Authorized Representative (LAR) to understand this study, and participant or LAR willingness to sign a written informed consent.
• Able to speak and read in the English language.
• Have a diagnosis of human epidermal growth factor receptor 2 (HER2) negative metastatic breast cancer.
• Participants must be enrolled in the parent registry study.

Exclusion Criteria:

• Genetic testing for a breast cancer gene (BRCA) BRCA1 and BRCA2 mutation completed after 2013 or any BRCA 1 and BRCA2 testing with large rearrangement testing. Prior genetic counseling is allowed.
• Psychiatric illness/social situations that would limit compliance with study requirements.